CRISPR nanoparticles are the next big hope in Alzheimer’s disease treatments
Nearly 6 million Americans live with Alzheimer's disease without solid treatment options.
Alternative medicine should be subject to scientific rigor, too
We need science, not hype, to hunt for ideas in traditional medicine